Globus Medical:连续七个季度利润率扩张,股价却未充分体现(纽交所代码:GMED)
· seekingalpha.com
Globus Medical 被评为买入,目标价在四个季度内实现17.5%的回报,基于稳定的10.56倍EV/EBITDA倍数。点击此处阅读GMED股票更新。
Globus Medical, Inc. ( GMED ) acquired Nevro in April 2025. As a result, every six-month comparison in the company filings mixes a quarter containing it against...